Mirabegron and Thyroid diseases - a phase IV clinical study of FDA data

Summary:

Thyroid diseases is reported only by a few people who take Mirabegron.

The phase IV clinical study analyzes which people take Mirabegron and have Thyroid diseases. It is created by eHealthMe based on reports of 3,418 people who have side effects while taking Mirabegron from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Mar, 19, 2023

3,418 people reported to have side effects when taking Mirabegron.
Among them, 2 people (0.06%) have Thyroid diseases.


What is Mirabegron?

Mirabegron has active ingredients of mirabegron. eHealthMe is studying from 3,441 Mirabegron users for its effectiveness, alternative drugs and more.

What is Thyroid diseases?

Thyroid diseases is found to be associated with 2,158 drugs and 1,522 conditions by eHealthMe.

Number of Mirabegron and Thyroid diseases reports submitted per year:

Could Mirabegron cause Thyroid diseases?

Gender of people who have Thyroid diseases when taking Mirabegron *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Thyroid diseases when taking Mirabegron *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Common drugs people take besides Mirabegron *:

  1. Vicodin: 1 person, 50.00%
  2. Lamictal: 1 person, 50.00%
  3. Ditropan: 1 person, 50.00%

Common side effects people have besides Thyroid diseases *:

  1. Weakness: 1 person, 50.00%
  2. Parkinson's Disease: 1 person, 50.00%
  3. Pain: 1 person, 50.00%
  4. Neuropathy Peripheral (surface nerve damage): 1 person, 50.00%
  5. Malaise (a feeling of general discomfort or uneasiness): 1 person, 50.00%
  6. Leukaemia (blood or bone marrow cancer): 1 person, 50.00%
  7. Ill-Defined Disorder: 1 person, 50.00%
  8. Glaucoma (increased fluid pressure in the eye with vision loss): 1 person, 50.00%
  9. General Physical Health Deterioration (weak health status): 1 person, 50.00%
  10. Gastric Disorder (disease of stomach): 1 person, 50.00%

Common conditions people have *:

  1. Urinary Incontinence (inability to control the flow of urine and involuntary urination): 1 person, 50.00%
  2. Bipolar Disorder (mood disorder): 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Mirabegron and have Thyroid diseases?

Check whether Thyroid diseases is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Thyroid diseases and when was it recovered:

Expand to all the drugs that have ingredients of mirabegron:

Alternative drugs to, pros and cons of Mirabegron:

Common Mirabegron side effects:

Browse all side effects of Mirabegron:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Thyroid diseases treatments and more:

COVID vaccines that are related to Thyroid diseases:

Common drugs associated with Thyroid diseases:

All the drugs that are associated with Thyroid diseases:

Common conditions associated with Thyroid diseases:

All the conditions that are associated with Thyroid diseases:

How the study uses the data?

The study uses data from the FDA. It is based on mirabegron (the active ingredients of Mirabegron) and Mirabegron (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: